文献速递类风湿关节炎

类风湿关节炎患者一级亲属对预防性治疗可接受风险的人群与心理预测因素

Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance.
PubMed 文献 · RMD Open · 2022-01-01

该偏好调查纳入289名类风湿关节炎患者的一级亲属,假设其2年内发病概率为60%,在获益固定(发病风险从60%降至20%)的条件下量化对预防性治疗风险的耐受度。结果显示,对40%发病风险降低,轻度副作用、严重感染和严重副作用的最大可接受风险均值分别为29.08%、9.09%和0.85%。年龄、感知发病概率和感知疾病持续时间与部分风险的耐受度相关。

要点

  • 对40%的发病风险降低,轻度副作用、严重感染和严重副作用的最大可接受风险均值分别为29.08%、9.09%和0.85%。
  • 60岁以上参与者对严重感染风险的耐受度低于年轻参与者(均值最大可接受风险相差±2.06%)。
  • 感知发病可能性更高者对轻度副作用风险的接受度更低(均值最大可接受风险相差±3.34%)。

核心结论

  • 年龄、感知发病概率和感知类风湿关节炎持续时间与对部分预防性治疗风险的耐受度相关。

研究设计与样本

  • 偏好调查纳入289名类风湿关节炎患者的一级亲属(80名男性),假设2年内发病概率为60%,在获益固定(发病风险从60%降至20%)条件下,采用概率阈值技术评估对假设预防性治疗风险的耐受度。

主要发现

  • 对40%的发病风险降低,轻度副作用、严重感染和严重副作用的最大可接受风险均值分别为29.08%、9.09%和0.85%。
  • 60岁以上参与者对严重感染风险的耐受度低于年轻参与者(均值最大可接受风险相差±2.06%)。
  • 感知发病可能性更高者对轻度副作用风险的接受度更低(均值最大可接受风险相差±3.34%)。
  • 认为若患类风湿关节炎将持续很长时间者对轻度副作用风险的接受度更高(均值最大可接受风险相差±4.44%)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To quantify tolerance to risks of preventive treatments among first-degree relatives (FDRs) of patients with rheumatoid arthritis (RA). METHODS: Preventive treatments for RA are under investigation. In a preference survey, adult FDRs assumed a 60% chance of developing RA within 2 years and made choices between no treatment and hypothetical preventive treatment options with a fixed level of benefit (reduction in chance of developing RA from 60% to 20%) and varying levels of risks. Using a probabilistic threshold technique, each risk was increased or decreased until participants switched their choice. Perceived risk of RA, health literacy, numeracy, Brief Illness Perception Questionnaire and Beliefs about Medicines Questionnaire-General were also assessed. Maximum acceptable risk (MAR) was summarised using descriptive statistics. Associations between MARs and participants' characteristics were assessed using interval regression with effects coding. RESULTS: 289 FDRs (80 male) responded. The mean MAR for a 40% reduction in chance of developing RA was 29.08% risk of mild side effects, 9.09% risk of serious infection and 0.85% risk of a serious side effect. Participants aged over 60 years were less tolerant of serious infection risk (mean MAR ±2.06%) than younger participants. Risk of mild side effects was less acceptable to participants who perceived higher likelihood of developing RA (mean MAR ±3.34%) and more acceptable to those believing that if they developed RA it would last for a long time (mean MAR ±4.44%). CONCLUSIONS: Age, perceived chance of developing RA and perceived duration of RA were associated with tolerance to some risks of preventive RA therapy.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Simons G, Janssen EM, Veldwijk J, et al. Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD Open. 2022. PMID: 36598004. doi:10.1136/rmdopen-2022-002593

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。